Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate NMB in Laparoscopic Gynaecological Surgery
NCT02794714Phase 4Withdrawn
- Sponsor
- Hospital Kuala Lumpur
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of Sugammadex (2 arms), sponsored by Hospital Kuala Lumpur. Primary endpoint: Surgical satisfaction of operating conditions. Planned start Jun 2016; status: withdrawn.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on NCT02794714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794714.